Evidence map›Paper›PMID 39587096›Full record

ArticleNature communications2024

Azocarboxamide-enabled enantioselective regiodivergent unsymmetrical 1,2-diaminations.

Yun-Dong Fu, Han Zhang, Bei-Bei Li, Lihua Huang, Xiao Xiao, Min-Can Wang, Donghui Wei, Guang-Jian Mei

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yun-Dong Fu *College of Chemistry, Zhengzhou University, Zhengzhou, 450001, China.
Han Zhang *College of Chemistry, Zhengzhou University, Zhengzhou, 450001, China.
Bei-Bei Li *College of Chemistry, Zhengzhou University, Zhengzhou, 450001, China.
Lihua HuangCollege of Chemistry, Zhengzhou University, Zhengzhou, 450001, China. hlh606@zzu.edu.cn.
Xiao XiaoCollaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, China.ORCID http://orcid.org/0000-0001-9138-8511
Min-Can WangCollege of Chemistry, Zhengzhou University, Zhengzhou, 450001, China.
Donghui WeiCollege of Chemistry, Zhengzhou University, Zhengzhou, 450001, China. donghuiwei@zzu.edu.cn.ORCID http://orcid.org/0000-0003-2820-282X
Guang-Jian MeiCollege of Chemistry, Zhengzhou University, Zhengzhou, 450001, China. meigj@zzu.edu.cn.ORCID http://orcid.org/0000-0002-8248-2327

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22371265
6 · The paper itself

Abstract

Enantioenriched unsymmetrical vicinal diamines are important basic structural motifs. While catalytic asymmetric intermolecular 1,2-diamination of carbon-carbon double bonds represents the most straightforward approach for preparing enantioenriched vicinal-diamine-containing heterocycles, these reactions are often limited to the installation of undifferentiated amino functionalities through metal catalysis and/or the use of stoichiometric amounts of oxidants. Here, we report organocatalytic enantioselective unsymmetrical 1,2-diaminations based on the rational design of a bifunctional 1,2-diamination reagent, namely, azocarboxamides (ACAs). Under the catalysis of chiral phosphoric acid, unsymmetrical 1,2-diaminations of ACAs with various electron-rich double bonds readily occur in a regiodivergent manner. Indoles prefer dual hydrogen-bonding mode to give dearomative (4 + 2) products, and 3-vinylindoles and azlactones are inclined to undergo unsymmetrical 1,2-diamination via the (3 + 2) process. DFT calculations are performed to reveal the reaction mechanism and the origin of the regio- and enantioselectivity. Guided by computational design, we are able to reverse the regioselectivity of the dearomative unsymmetrical 1,2-diamination of indoles using Lewis acid catalysis.

Identifiers

PMID39587096
PMCPMC11589106

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.